EQT AB is nearing a deal to acquire Qiagen NV for around €9. 6 billion ($10. 8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-10-21/eqt-nears-9-6-billion-deal-for-molecular-testing-firm-qiagen)